Pfizer, AstraZeneca, LVMH, Ikos: Intellectual Property

Pfizer Inc. said it filed patent-infringement lawsuits yesterday against generic-drug makers including Teva Pharmaceutical Industries Ltd. to prevent them from selling a low-cost version of the painkiller Celebrex until December 2015.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.